Global Antiparasitic Drugs Market Overview:
Global Antiparasitic Drugs Market is expected to grow at a significant rate during the forecast period 2026-2035, with 2024 as the base year.
Global Antiparasitic Drugs Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Antiparasitic Drugs involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Antiparasitic Drugs Market:
The Antiparasitic Drugs Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Antiparasitic Drugs Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Antiparasitic Drugs Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Antiparasitic Drugs market has been segmented into:
Anthelmintics (Anticestodal Drugs
Antitrematodal Drugs
and Antinematodal Drugs
By Application, Antiparasitic Drugs market has been segmented into:
Antimalarials Agents Antibabesial Agents
Antiamoebic Agents
and Others (Trypanocidal Agents
Antileishmanial Agents
etc.
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Antiparasitic Drugs market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Antiparasitic Drugs market.
Top Key Players Covered in Antiparasitic Drugs market are:
Merck KGaA
GlaxoSmithKline plc
Dr. Reddy’s Laboratories Ltd
Cipla Limited
Cadila Pharmaceuticals
Watson International Limited
Vivaldis
Glenmark Pharmaceuticals Limited
Viatris Inc.
Novartis AG
AdvaCare Pharma
Lupin
Sun Pharmaceutical Industries Ltd.
Aurobindo Pharma
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Antiparasitic Drugs Market by Type
4.1 Antiparasitic Drugs Market Snapshot and Growth Engine
4.2 Antiparasitic Drugs Market Overview
4.3 Anthelmintics (Anticestodal Drugs
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Anthelmintics (Anticestodal Drugs: Geographic Segmentation Analysis
4.4 Antitrematodal Drugs
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Antitrematodal Drugs: Geographic Segmentation Analysis
4.5 and Antinematodal Drugs
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 and Antinematodal Drugs: Geographic Segmentation Analysis
Chapter 5: Antiparasitic Drugs Market by Application
5.1 Antiparasitic Drugs Market Snapshot and Growth Engine
5.2 Antiparasitic Drugs Market Overview
5.3 Antimalarials Agents Antibabesial Agents
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Antimalarials Agents Antibabesial Agents: Geographic Segmentation Analysis
5.4 Antiamoebic Agents
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Antiamoebic Agents: Geographic Segmentation Analysis
5.5 and Others (Trypanocidal Agents
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 and Others (Trypanocidal Agents: Geographic Segmentation Analysis
5.6 Antileishmanial Agents
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Antileishmanial Agents: Geographic Segmentation Analysis
5.7 etc.
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 etc.: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Antiparasitic Drugs Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 MERCK KGAA
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 GLAXOSMITHKLINE PLC
6.4 DR. REDDY’S LABORATORIES LTD
6.5 CIPLA LIMITED
6.6 CADILA PHARMACEUTICALS
6.7 WATSON INTERNATIONAL LIMITED
6.8 VIVALDIS
6.9 GLENMARK PHARMACEUTICALS LIMITED
6.10 VIATRIS INC.
6.11 NOVARTIS AG
6.12 ADVACARE PHARMA
6.13 LUPIN
6.14 SUN PHARMACEUTICAL INDUSTRIES LTD.
6.15 AND AUROBINDO PHARMA
Chapter 7: Global Antiparasitic Drugs Market By Region
7.1 Overview
7.2. North America Antiparasitic Drugs Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Anthelmintics (Anticestodal Drugs
7.2.4.2 Antitrematodal Drugs
7.2.4.3 and Antinematodal Drugs
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Antimalarials Agents Antibabesial Agents
7.2.5.2 Antiamoebic Agents
7.2.5.3 and Others (Trypanocidal Agents
7.2.5.4 Antileishmanial Agents
7.2.5.5 etc.
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Antiparasitic Drugs Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Anthelmintics (Anticestodal Drugs
7.3.4.2 Antitrematodal Drugs
7.3.4.3 and Antinematodal Drugs
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Antimalarials Agents Antibabesial Agents
7.3.5.2 Antiamoebic Agents
7.3.5.3 and Others (Trypanocidal Agents
7.3.5.4 Antileishmanial Agents
7.3.5.5 etc.
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Antiparasitic Drugs Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Anthelmintics (Anticestodal Drugs
7.4.4.2 Antitrematodal Drugs
7.4.4.3 and Antinematodal Drugs
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Antimalarials Agents Antibabesial Agents
7.4.5.2 Antiamoebic Agents
7.4.5.3 and Others (Trypanocidal Agents
7.4.5.4 Antileishmanial Agents
7.4.5.5 etc.
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Antiparasitic Drugs Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Anthelmintics (Anticestodal Drugs
7.5.4.2 Antitrematodal Drugs
7.5.4.3 and Antinematodal Drugs
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Antimalarials Agents Antibabesial Agents
7.5.5.2 Antiamoebic Agents
7.5.5.3 and Others (Trypanocidal Agents
7.5.5.4 Antileishmanial Agents
7.5.5.5 etc.
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Antiparasitic Drugs Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Anthelmintics (Anticestodal Drugs
7.6.4.2 Antitrematodal Drugs
7.6.4.3 and Antinematodal Drugs
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Antimalarials Agents Antibabesial Agents
7.6.5.2 Antiamoebic Agents
7.6.5.3 and Others (Trypanocidal Agents
7.6.5.4 Antileishmanial Agents
7.6.5.5 etc.
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Antiparasitic Drugs Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Anthelmintics (Anticestodal Drugs
7.7.4.2 Antitrematodal Drugs
7.7.4.3 and Antinematodal Drugs
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Antimalarials Agents Antibabesial Agents
7.7.5.2 Antiamoebic Agents
7.7.5.3 and Others (Trypanocidal Agents
7.7.5.4 Antileishmanial Agents
7.7.5.5 etc.
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Antiparasitic Drugs Scope:
|
Report Data
|
Antiparasitic Drugs Market
|
|
Antiparasitic Drugs Market Size in 2025
|
USD XX million
|
|
Antiparasitic Drugs CAGR 2025 - 2032
|
XX%
|
|
Antiparasitic Drugs Base Year
|
2024
|
|
Antiparasitic Drugs Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Merck KGaA, GlaxoSmithKline plc, Dr. Reddy’s Laboratories Ltd, Cipla Limited, Cadila Pharmaceuticals, Watson International Limited, Vivaldis, Glenmark Pharmaceuticals Limited, Viatris Inc., Novartis AG, AdvaCare Pharma, Lupin, Sun Pharmaceutical Industries Ltd., and Aurobindo Pharma.
|
|
Key Segments
|
By Type
Anthelmintics (Anticestodal Drugs
Antitrematodal Drugs
and Antinematodal Drugs
By Applications
Antimalarials Agents Antibabesial Agents
Antiamoebic Agents
and Others (Trypanocidal Agents
Antileishmanial Agents
etc.
|
